A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study.

ZÁVADA, Jakub; Michal UHER; Katarina SISOL; Šárka FOREJTOVÁ; Kateřina JAROŠOVÁ; Heřman F. MANN; Jiří VENCOVSKÝ and Karel PAVELKA. A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study. In ARTHRITIS & RHEUMATOLOGY. 2014. ISSN 2326-5191.

Basic information

Original name

A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study.

Authors

ZÁVADA, Jakub; Michal UHER; Katarina SISOL; Šárka FOREJTOVÁ; Kateřina JAROŠOVÁ; Heřman F. MANN; Jiří VENCOVSKÝ and Karel PAVELKA

Edition

ARTHRITIS & RHEUMATOLOGY, 2014

---

Other information

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Institute of Biostatistics and Analyses

ISSN

UT WoS

000344384901395